| ID Source | ID |
|---|---|
| PubMed CID | 9957280 |
| CHEMBL ID | 1551597 |
| CHEBI ID | 93374 |
| SCHEMBL ID | 7395227 |
| Synonym |
|---|
| BRD-K78122587-300-01-9 |
| NCGC00161421-01 |
| NCGC00161421-02 |
| MET7ZRB8Y7 , |
| 357400-14-7 |
| nnc-55-0396 free base |
| cyclopropanecarboxylic acid, (1s,2s)-2-(2-((3-(1h-benzimidazol-2-yl)propyl)methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-(1-methylethyl)-2-naphthalenyl ester |
| [(1s,2s)-2-[2-[3-(1h-benzimidazol-2-yl)propyl-methylamino]ethyl]-6-fluoro-1-propan-2-yl-3,4-dihydro-1h-naphthalen-2-yl] cyclopropanecarboxylate |
| gtpl4269 |
| SCHEMBL7395227 |
| unii-met7zrb8y7 |
| CHEMBL1551597 , |
| CHEBI:93374 |
| bdbm50561000 |
| Q27087972 |
| DTXSID001018002 |
| (1s,2s)-2-(2-{[3-(1h-benzimidazol-2-yl)propyl](methyl)amino}ethyl)-6-fluoro-1-(2-propanyl)-1,2,3,4-tetrahydro-2-naphthalenyl cyclopropanecarboxylate |
| Role | Description |
|---|---|
| antineoplastic agent | A substance that inhibits or prevents the proliferation of neoplasms. |
| angiogenesis inhibitor | An agent and endogenous substances that antagonize or inhibit the development of new blood vessels. |
| apoptosis inducer | Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms. |
| neuroprotective agent | Any compound that can be used for the treatment of neurodegenerative disorders. |
| potassium channel blocker | An agent that inhibits cell membrane glycoproteins that are selectively permeable to potassium ions. |
| T-type calcium channel blocker | Any agent that interferes with the activity of T-type calcium channels. |
| [role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Class | Description |
|---|---|
| benzimidazoles | An organic heterocyclic compound containing a benzene ring fused to an imidazole ring. |
| tetralins | Compounds containing a tetralin skeleton. |
| organofluorine compound | An organofluorine compound is a compound containing at least one carbon-fluorine bond. |
| cyclopropanecarboxylate ester | A carboxylic ester resulting from the formal condensation of the hydroxy group of an alcohol or phenol with the carboxy group of cyclopropanecarboxylic acid or its substituted derivatives. |
| tertiary amino compound | A compound formally derived from ammonia by replacing three hydrogen atoms by organyl groups. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| Chain A, Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | 19.9054 | 0.1409 | 11.1940 | 39.8107 | AID2451 |
| phosphopantetheinyl transferase | Bacillus subtilis | Potency | 44.6684 | 0.1413 | 37.9142 | 100.0000 | AID1490 |
| TDP1 protein | Homo sapiens (human) | Potency | 4.7394 | 0.0008 | 11.3822 | 44.6684 | AID686978; AID686979 |
| Microtubule-associated protein tau | Homo sapiens (human) | Potency | 19.9526 | 0.1800 | 13.5574 | 39.8107 | AID1460 |
| Smad3 | Homo sapiens (human) | Potency | 11.2202 | 0.0052 | 7.8098 | 29.0929 | AID588855 |
| aldehyde dehydrogenase 1 family, member A1 | Homo sapiens (human) | Potency | 31.6228 | 0.0112 | 12.4002 | 100.0000 | AID1030 |
| 67.9K protein | Vaccinia virus | Potency | 18.0635 | 0.0001 | 8.4406 | 100.0000 | AID720579; AID720580 |
| glucocerebrosidase | Homo sapiens (human) | Potency | 28.1838 | 0.0126 | 8.1569 | 44.6684 | AID2101 |
| euchromatic histone-lysine N-methyltransferase 2 | Homo sapiens (human) | Potency | 12.5893 | 0.0355 | 20.9770 | 89.1251 | AID504332 |
| flap endonuclease 1 | Homo sapiens (human) | Potency | 44.6684 | 0.1337 | 25.4129 | 89.1251 | AID588795 |
| nuclear receptor ROR-gamma isoform 1 | Mus musculus (house mouse) | Potency | 33.5521 | 0.0079 | 8.2332 | 1,122.0200 | AID2546; AID2551 |
| DNA polymerase kappa isoform 1 | Homo sapiens (human) | Potency | 39.8107 | 0.0316 | 22.3146 | 100.0000 | AID588579 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) | Potency | 3.1623 | 0.3162 | 12.7657 | 31.6228 | AID881 |
| Alpha-synuclein | Homo sapiens (human) | Potency | 31.6228 | 0.5623 | 9.3985 | 25.1189 | AID652106 |
| Histamine H2 receptor | Cavia porcellus (domestic guinea pig) | Potency | 3.1623 | 0.0063 | 8.2350 | 39.8107 | AID881 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| Voltage-dependent T-type calcium channel subunit alpha-1H | Homo sapiens (human) | IC50 (µMol) | 2.0000 | 0.0320 | 1.0479 | 3.6000 | AID1724015 |
| Voltage-dependent N-type calcium channel subunit alpha-1B | Homo sapiens (human) | IC50 (µMol) | 7.0000 | 0.0400 | 4.1137 | 10.0000 | AID1724014 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1724014 | Inhibition of human N type calcium channel Cav2.2 endogenously expressed in SH-SY5Y cells assessed as calcium influx by FRIPR assay | 2020 | Bioorganic & medicinal chemistry, 09-15, Volume: 28, Issue:18 | The neuronal calcium ion channel activity of constrained analogues of MONIRO-1. |
| AID1724015 | Inhibition of human T type calcium channel Cav3.2 expressed in HEK-293T cells assessed as calcium influx by FRIPR assay | 2020 | Bioorganic & medicinal chemistry, 09-15, Volume: 28, Issue:18 | The neuronal calcium ion channel activity of constrained analogues of MONIRO-1. |
| AID1347154 | Primary screen GU AMC qHTS for Zika virus inhibitors | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49 | Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
| AID1508630 | Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay | 2021 | Cell reports, 04-27, Volume: 35, Issue:4 | A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. |
| AID1346461 | Mouse CatSper1 (CatSper and Two-Pore channels) | 2011 | Nature, Mar-17, Volume: 471, Issue:7338 | Progesterone activates the principal Ca2+ channel of human sperm. |
| AID1346507 | Mouse CatSper4 (CatSper and Two-Pore channels) | 2011 | Nature, Mar-17, Volume: 471, Issue:7338 | Progesterone activates the principal Ca2+ channel of human sperm. |
| AID1346448 | Human CatSper2 (CatSper and Two-Pore channels) | 2011 | Nature, Mar-17, Volume: 471, Issue:7338 | The CatSper channel mediates progesterone-induced Ca2+ influx in human sperm. |
| AID1346479 | Mouse CatSper3 (CatSper and Two-Pore channels) | 2011 | Nature, Mar-17, Volume: 471, Issue:7338 | Progesterone activates the principal Ca2+ channel of human sperm. |
| AID1346462 | Human CatSper1 (CatSper and Two-Pore channels) | 2011 | Nature, Mar-17, Volume: 471, Issue:7338 | Progesterone activates the principal Ca2+ channel of human sperm. |
| AID1346536 | Human CatSper3 (CatSper and Two-Pore channels) | 2011 | Nature, Mar-17, Volume: 471, Issue:7338 | Progesterone activates the principal Ca2+ channel of human sperm. |
| AID1346498 | Human CatSper4 (CatSper and Two-Pore channels) | 2011 | Nature, Mar-17, Volume: 471, Issue:7338 | The CatSper channel mediates progesterone-induced Ca2+ influx in human sperm. |
| AID1346462 | Human CatSper1 (CatSper and Two-Pore channels) | 2011 | Nature, Mar-17, Volume: 471, Issue:7338 | The CatSper channel mediates progesterone-induced Ca2+ influx in human sperm. |
| AID1346536 | Human CatSper3 (CatSper and Two-Pore channels) | 2011 | Nature, Mar-17, Volume: 471, Issue:7338 | The CatSper channel mediates progesterone-induced Ca2+ influx in human sperm. |
| AID1346498 | Human CatSper4 (CatSper and Two-Pore channels) | 2011 | Nature, Mar-17, Volume: 471, Issue:7338 | Progesterone activates the principal Ca2+ channel of human sperm. |
| AID1346447 | Mouse CatSper2 (CatSper and Two-Pore channels) | 2011 | Nature, Mar-17, Volume: 471, Issue:7338 | Progesterone activates the principal Ca2+ channel of human sperm. |
| AID1346448 | Human CatSper2 (CatSper and Two-Pore channels) | 2011 | Nature, Mar-17, Volume: 471, Issue:7338 | Progesterone activates the principal Ca2+ channel of human sperm. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||